Home Relationship between polymorphisms in the CRP, LEP and LEPR genes and high sensitivity C-reactive protein levels in Spanish children
Article
Licensed
Unlicensed Requires Authentication

Relationship between polymorphisms in the CRP, LEP and LEPR genes and high sensitivity C-reactive protein levels in Spanish children

  • Pilar Navarro , Olaya de Dios , Teresa Gavela-Pérez , Leandro Soriano-Guillen and Carmen Garcés EMAIL logo
Published/Copyright: March 28, 2017

Abstract

Background:

We investigated the association of single nucleotide polymorphisms (SNPs) in the C-reactive protein (CRP), leptin (LEP) and leptin receptor (LEPR) genes with high sensitivity CRP (hs-CRP) levels in two independent cohorts of healthy Spanish children.

Methods:

We measured hs-CRP levels in 646 6–8-year-old and 707 12–16-year-old children using a high-sensitivity C-Reactive Protein ELISA kit. Four SNPs in the CRP gene (rs1205, rs1130864, rs2794521 and rs1800947), one SNP in the LEP gene (rs7799039) and two SNPs in the LEPR (rs1137100 and rs1137101) gene were determined by TaqMan® allelic discrimination assays.

Results:

The four CRP SNPs studied were significantly (p<0.05) associated with hs-CRP levels in both cohorts. Furthermore, two common CRP haplotypes (constructed using the SNPs in order: rs1205, rs1130864, rs1800947, rs2794521) ACGA and GCGG were associated with significantly lower CRP levels (p<0.05) at both ages. The LEPR SNPs rs1137100 (K109R) and rs1137101 (Q223R), and LEP SNP rs7799039 (G2548A) were also associated to hs-CRP levels (p<0.05) in both cohorts.

Conclusions:

hs-CRP levels in healthy Spanish children, besides being associated to common polymorphisms in the CRP gene, are associated to polymorphisms in the LEP and LEPR genes, which suggests that other loci, in addition the CRP gene, may have a role determining CRP levels in children.


Corresponding author: Dr. Carmen Garcés, Lipid Research Laboratory, IIS-Fundación Jiménez Díaz, Avda. Reyes Católicos, 2. 28040 Madrid, Spain, Phone: +34-91-5432880

Acknowledgments

This article is dedicated to the late Prof. Manuel de Oya as the warmest homage to his memory. Prof. de Oya designed the Four Province Study.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This work was supported by a grant from the Fondo de Investigación Sanitaria /FEDER (FIS14/00344) and Biobank grant FEDER RD09/0076/00101.

  3. Employment or leadership: Pilar Navarro and Olaya de Dios are fellows of the Conchita Rábago Foundation.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972–8.10.1161/01.ATV.19.4.972Search in Google Scholar PubMed

2. Choi J, Joseph L, Pilote L. Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev 2013;14:232–4.10.1111/obr.12003Search in Google Scholar PubMed

3. Carlson CS, Alfred SF, Lee PK, Tracy RP, Schwartz SM, Rieder M, et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP plasma. Am J Hum Genet 2005;77:64–77.10.1086/431366Search in Google Scholar PubMed PubMed Central

4. Kathiresan S, Larson MG, Vagan RS, Guo CY, Gona P, Keaney JF Jr, et al. Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 2006;113: 1415–23.10.1161/CIRCULATIONAHA.105.591271Search in Google Scholar PubMed

5. Danik JS, Ridker PM. Genetic determinants of C-reactive protein. Curr Atheroscler Rep 2007;9:195–203.10.1007/s11883-007-0019-2Search in Google Scholar PubMed

6. Hage FG, Szalai AJ. The role of C-reactive protein polymorphisms in inflammation and cardiovascular risk. Curr Atheroscler Rep 2009;11:124–30.10.1007/s11883-009-0020-zSearch in Google Scholar PubMed

7. Martínez-Calatrava MJ, González-Sánchez JL, Martínez-Larrad MT, Pérez-Barba M, Serrano-Ríos M. Common haplotypes of the C-reactive protein gene and circulating leptin levels influence the interindividual variability in serum C-reactive protein levels. The Segovia study. Thromb Haemost 2007;98:1088–95.10.1160/TH07-03-0231Search in Google Scholar PubMed

8. Komurcu-Bayrak E, Erginel-Unaltuna N, Onat A, Ozsait B, Eklund C, Hurme M, et al. Association of C-reactive protein (CRP) gene allelic variants with serum CRP levels and hypertension in Turkish adults. Atherosclerosis 2009;206:474–9.10.1016/j.atherosclerosis.2009.03.030Search in Google Scholar PubMed

9. Kong H, Qian YS, Tang XF, Zhang J, Gao PJ, Zhang Y, et al. C-reactive protein (CRP) gene polymorphism, CRP levels and risk of incident essential hypertension: findings from an observational cohort of Han Chinese. Hypertens Res 2012;35:1019–23.10.1038/hr.2012.89Search in Google Scholar PubMed

10. Martínez-Calleja A, Quiróz-Vargas I, Parra-Rojas I, Muñoz-Valle JF, Leyva-Vázquez MA, Fernández-Tilapa G, et al. Haplotypes in the CRP gene associated with increased BMI and levels of CRP in subjects with type 2 diabetes or obesity from Southwestern Mexico. Exp Diabetes Res 2012;2012:982683.10.1155/2012/982683Search in Google Scholar PubMed PubMed Central

11. Lee CC, You NC, Song Y, Hsu YH, Manson J, Nathan L, et al. Relation of genetic variation in the gene coding for C-reactive protein with its plasma protein concentrations: findings from the Women’s Health Initiative Observational Cohort. Clin Chem 2009;55:351–60.10.1373/clinchem.2008.117176Search in Google Scholar PubMed

12. Crawford DC, Sanders CL, Qin X, Smith JD, Shephard C, Wong M, et al. Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation 2006;114:2458–65.10.1161/CIRCULATIONAHA.106.615740Search in Google Scholar PubMed

13. Li SP, Liu TY, Goldman ND. cis-acting elements responsible for interleukin-6 inducible C-reactive protein gene expression. J Biol Chem 1990;265:4136–42.10.1016/S0021-9258(19)39713-3Search in Google Scholar PubMed

14. Mendoza-Carrera F, Ramírez-López G, Ayala-Martínez NA, García-Zapién AG, Flores-Martínez SE, Sánchez-Corona J. influence of CRP, IL-6, and TNFA gene polymorphisms on circulating levels of C-reactive protein in mexican adolescents. Arch Med Res 2010;41:472–7.10.1016/j.arcmed.2010.08.015Search in Google Scholar PubMed

15. Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 2000;68: 437–46.10.1189/jlb.68.4.437Search in Google Scholar PubMed

16. Nakamura Y, Ueshima H, Okuda N, Miura K, Kita Y, Okamura T, et al. Relation of Serum Leptin and Adiponectin Level to Serum C-Reactive Protein: The INTERLIPID Study. Int J Vasc Med 2013;2013:601364.10.1155/2013/601364Search in Google Scholar PubMed PubMed Central

17. Stakos DA, Papaioannou HI, Angelidou I, Mantadakis E, Paraskakis E, Tsigalou C, et al. Plasma leptin and adiponectin concentrations correlate with cardiometabolic risk and systemic inflammation in healthy, non-obese children. J Pediatr Endocrinol Metab 2014;27:221–8.10.1515/jpem-2013-0195Search in Google Scholar PubMed

18. Hribal ML, Fiorentino TV, Sesti G. Role of C reactive protein (CRP) in leptin resistance. Curr Pharm Des 2014;20:609–15.10.2174/13816128113199990016Search in Google Scholar PubMed PubMed Central

19. Navarro P, de Dios O, Gavela-Perez T, Jois A, Garces C, Soriano-Guillén L. High-sensitivity C-reactive protein and leptin levels related to Body Mass Index changes troughtout childhood. J Pediatr 2016;178:178–82.10.1016/j.jpeds.2016.08.020Search in Google Scholar PubMed

20. Riestra P, García-Anguita A, Schoppen S, López-Simón L, De Oya M, Garcés C. Sex-specific association between leptin receptor polymorphisms and leptin levels and BMI in healthy adolescents. Acta Paediatr 2010;99:1527–30.10.1111/j.1651-2227.2010.01877.xSearch in Google Scholar PubMed

21. Riestra P, García-Anguita A, Viturro E, Schoppen S, De Oya M, Garcés C. Influence of the leptin G-2548A polymorphism on leptin levels and anthropometric measurements in healthy Spanish adolescents. Ann Hum Genet 2010;74:335–9.10.1111/j.1469-1809.2010.00586.xSearch in Google Scholar PubMed

22. Schumacher W, Cockcroft J, Timpson NJ, McEniery CM, Gallacher J, Rumley A, et al. Association between C-reactive protein genotype, circulating levels, and aortic pulse wave velocity. Hypertension 2009;53:150–57.10.1161/HYPERTENSIONAHA.108.117622Search in Google Scholar PubMed

23. Russell AI, Cunninghame-Graham DS, Shepherd C, Roberton CA, Whittaker J, Meeks J, et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 2004;13:137–47.10.1093/hmg/ddh021Search in Google Scholar PubMed PubMed Central

24. Kotlęga D, Białecka M, Kurzawski M, Droździk M, Ciećwież S, Gołąb-Janowska M, Nowacki P. Risk factors of stroke and -717A>G (rs2794521) CRP gene polymorphism among stroke patients in West Pomerania province of Poland. Neurol Neurochir Pol 2014;48:30–4.10.1016/j.pjnns.2013.12.001Search in Google Scholar PubMed

25. Wang L, Lu X, Li Y, Li H, Chen S, Gu D. Functional analysis of the C-reactive protein (CRP) gene -717 A>G polymorphism associated with coronary heart disease. BMC Med Genet 2009;10:73.10.1186/1471-2350-10-73Search in Google Scholar PubMed PubMed Central

26. Kivimäki M, Lawlor DA, Smith GD, Eklund C, Hurme M, Lehtimäki T, et al. Variants in the CRP gene as a measure of lifelong differences in average C-reactive protein levels: the Cardiovascular Risk in Young Finns study, 1980–2001. Am J Epidemiol 2007;166:760–4.10.1093/aje/kwm151Search in Google Scholar PubMed

27. Ridker PM, Pare G, Parker A, Zee RY, Danik JS, Buring JE, et al. Loci related to metabolic-syndrome pathways including LEPR. HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women’s Genome Health Study. Am J Hum Genet 2008;82:1185–92.10.1016/j.ajhg.2008.03.015Search in Google Scholar PubMed PubMed Central

28. Reiner AP, Beleza S, Franceschini N, Auer PL, Robinson JG, Kooperberg C, et al. Genome-wide association and population genetic analysis of C-reactive protein in African American and Hispanic American women. Am J Hum Genet 2012;91:502–12.10.1016/j.ajhg.2012.07.023Search in Google Scholar PubMed PubMed Central

29. Zang YY, Gottardo L, Mlynarski W, Frazier W, Nolan D, Duffy J, et al. Genetic variability at the leptin receptor (LEPR) locus is a determinant of plasma fibrinogen and C-reactive protein levels. Atherosclerosis 2007;191:121–7.10.1016/j.atherosclerosis.2006.02.043Search in Google Scholar PubMed

30. Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, Peden JF, et al. Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. J Am Med Assoc 2009;302:37–48.10.1001/jama.2009.954Search in Google Scholar PubMed PubMed Central

31. Curocichin G, Wu Y, McDade TW, Kuzawa CW, Borja JB, Qin L, et al. Single-nucleotide polymorphisms at five loci are associated with C-reactive protein levels in a cohort of Filipino young adults. J Hum Genet 2011;56:823–7.10.1038/jhg.2011.106Search in Google Scholar PubMed PubMed Central

Received: 2017-2-16
Accepted: 2017-2-19
Published Online: 2017-3-28
Published in Print: 2017-10-26

©2017 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. High-sensitivity assays for cardiac troponins – continued
  4. Reviews
  5. The 99th percentile of reference population for cTnI and cTnT assay: methodology, pathophysiology and clinical implications
  6. Vitamin B1 in critically ill patients: needs and challenges
  7. Opinion Papers
  8. Point
  9. High-sensitivity cardiac troponin: do think twice, it’s not all right
  10. Counterpoint
  11. Terminology of cardiac troponin assays and data censoring
  12. Establishing consensus-based, assay-specific 99th percentile upper reference limits to facilitate proper utilization of cardiac troponin measurements
  13. Fast track protocols using highly sensitive troponin assays for ruling out and ruling in non-ST elevation acute coronary syndrome
  14. Genetics and Molecular Diagnostics
  15. Relationship between polymorphisms in the CRP, LEP and LEPR genes and high sensitivity C-reactive protein levels in Spanish children
  16. General Clinical Chemistry and Laboratory Medicine
  17. An approach for estimating measurement uncertainty in medical laboratories using data from long-term quality control and external quality assessment schemes
  18. Selecting multi-rule quality control procedures based on patient risk
  19. Moving sum of number of positive patient result as a quality control tool
  20. Multidisciplinary training activities for decreasing preanalytical mistakes in samples from primary care
  21. Harmonization protocols for TSH immunoassays: a multicenter study in Italy
  22. Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays
  23. Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia
  24. Temporal and regional variability in the request of vitamin D from general practitioners in Spain
  25. Fibrinogen determination according to Clauss: commutability assessment of International and commercial standards and quality control samples
  26. Reference Values and Biological Variations
  27. S100B maternal blood levels are gestational age- and gender-dependent in healthy pregnancies
  28. Gestational age-specific reference intervals for serum thyroid hormone levels in a multi-ethnic population
  29. Cancer Diagnostics
  30. Serum complexed and free prostate-specific antigen (PSA) for the diagnosis of the polycystic ovarian syndrome (PCOS)
  31. Cardiovascular Diseases
  32. A new immunochemistry platform for a guideline-compliant cardiac troponin T assay at the point of care: proof of principle
  33. Diabetes
  34. Adiponectin and leptin as first trimester markers for gestational diabetes mellitus: a cohort study
  35. Letters to the Editor
  36. Can we still trust hemoglobin A1c in all situations?
  37. Automated detection of unstable hemoglobin variants by Sysmex XE-Series analyzers
  38. Mean hemoglobin concentrations in fasting venous and non-fasting capillary blood of Cambodian women using a hemoglobinometer and an automated hematology analyzer
  39. Evaluation of a POCT device for C-reactive protein, hematocrit and leukocyte differential
  40. New perspectives on existing data in comparative measurements: a simple extension of the regression analysis
  41. Evaluation of a human anti-mouse antibody rapid test for patients requiring radio-immunodiagnostic
  42. The cortisol-CBG ratio affects cortisol immunoassay bias at elevated CBG concentrations
  43. Prognostic value of total antioxidant capacity to predict functional outcome in traumatic brain injury patients
  44. Use of IFCC guidelines to verify acetylcholinesterase reference interval in adults determined with ChE check mobile testing system
  45. Congress Abstracts
  46. 49th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC – Laboratory Medicine)
  47. Congress of Clinical Chemistry and Laboratory Medicine
Downloaded on 19.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2017-0134/html
Scroll to top button